Leap Therapeutics Announces Appointment of Richard L. Schils

/PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Related Keywords

Australia , Japan , Cambridge , Cambridgeshire , United Kingdom , United States , New Zealand , American , Matthew Deyoung , Christopher Mirabelli , Douglase Onsi , Richardl Schilsky , American Society Of Clinical Oncology , National Cancer Institute , University Of Chicago Pritzker School Medicine , Dean For Clinical Research , Nasdaq , University Of Chicago , Leap Therapeutics Inc , Department Of Medicine , Translational Research Committee , Leukemia Group , Drug Administration , Sciences Division , Beigene Ltd , Oncologic Drugs Advisory Committee , Securities Exchange , University Of Pennsylvania , University Of Chicago Cancer Research Center , Leap Therapeutics , Leap Therapeutic , Drugs Advisory , Chief Medical Officer , Executive Vice President , American Society , Clinical Oncology , Associate Dean , Clinical Research , Biological Sciences Division , Chicago Cancer Research , Scientific Advisors , New England Journal , Chicago Pritzker School , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nc ,